Adaptimmune Therapeutics PLC Contracts & Agreements

84 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Variation Agreement to Redundancy Terms between Adaptimmune Therapeutics plc and Gavin Wood
Separation Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2025
First Amendment to Loan and Security Agreement by and among Adaptimmune Therapeutics PLC, Affiliates, Hercules Capital, Inc., and Lenders (March 24, 2025)
Loan Agreements
Adaptimmune Therapeutics PLC
Biotechnology
CA
2025
Separation Agreement between Adaptimmune Therapeutics plc and Dr. Helen Tayton-Martin (December 2024)
Severance Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2024
Severance Agreement between Adaptimmune Therapeutics plc and Gavin Wood dated December 18, 2024
Severance Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2024
Mutual Release and Resolution Agreement between Adaptimmune Limited, Genentech, Inc., and F. Hoffmann-La Roche Ltd (September 23, 2024)
Settlement Agreements
Adaptimmune Therapeutics PLC
Biotechnology
NY
2024
Amended and Restated Executive Severance Policy of Adaptimmune Therapeutics plc (Effective July 16, 2024)
Severance Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2024
Amended and Restated Executive Severance Policy of Adaptimmune Therapeutics plc
Severance Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2024
Description of Registered Securities of Adaptimmune Therapeutics plc under Section 12 of the Exchange Act
Equity Distribution Agreements
Adaptimmune Therapeutics PLC
Biotechnology
NY
2024
Employment Agreement between Adaptimmune, LLC and Cintia Piccina (Chief Commercial Officer)
Employment Agreements
Adaptimmune Therapeutics PLC
Biotechnology
PA
2024
Adaptimmune Therapeutics plc 2015 Share Option Scheme Rules (as Amended)
Stock Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2023
Adaptimmune Therapeutics plc 2016 Employee Share Option Scheme Rules (as Amended)
Bonus & Incentive Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2023
Separation Agreement and Release between TCR2 Therapeutics Inc. and Garry E. Menzel, Ph.D.
Separation Agreements
Adaptimmune Therapeutics PLC
Biotechnology
MA
2023
Adaptimmune Therapeutics plc Non-Executive Director Appointment Letter – Andrew Allen
Employment Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2023
Adaptimmune Therapeutics plc Non-Executive Director Appointment Letter – Dr. Priti Hegde
Employment Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2023
Adaptimmune Therapeutics plc Non-Executive Director Appointment Letter – Dr. Garry Menzel (June 2023)
Employment Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2023
Termination and Transfer Agreement between Adaptimmune Limited and GlaxoSmithKline Intellectual Property Development Limited (April 6, 2023)
Termination Agreements
Adaptimmune Therapeutics PLC
Biotechnology
CA
2023
Amendment No. 1 to Agreement and Plan of Merger among Adaptimmune Therapeutics plc, CM Merger Sub, Inc., and TCR2 Therapeutics Inc.
Merger Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2023
Description of Securities Registered Under Section 12 of the Exchange Act – Adaptimmune Therapeutics plc
Equity Distribution Agreements
Adaptimmune Therapeutics PLC
Biotechnology
NY
2023
Agreement and Plan of Merger among Adaptimmune Therapeutics plc, CM Merger Sub, Inc., and TCR2 Therapeutics Inc. dated March 5, 2023
Merger Agreements
Adaptimmune Therapeutics PLC
Biotechnology
DE
2023
Voting and Support Agreement among Adaptimmune Therapeutics PLC, TCR2 Therapeutics Inc., and Stockholder (March 5, 2023)
Voting Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2023
Voting and Support Agreement among Adaptimmune Therapeutics PLC, TCR2 Therapeutics Inc., and Shareholder (March 5, 2023)
Voting Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2023
Separation and Consulting Agreement between Adaptimmune, LLC and Cintia Piccina
Separation Agreements
Adaptimmune Therapeutics PLC
Biotechnology
PA
2023
Amendment Agreement No. 8 to Collaboration and Licence Agreement between Adaptimmune Limited and GlaxoSmithKline Intellectual Property Development Ltd
Modification Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2022
Employment Agreement between Adaptimmune Limited and Joanna Brewer dated May 4, 2022
Employment Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2022
Description of Ordinary Shares Registered Under Section 12 of the Exchange Act – Adaptimmune Therapeutics plc
Stock Agreements
Adaptimmune Therapeutics PLC
Biotechnology
NY
2022
Employment Agreement between Adaptimmune, LLC and Cintia Piccina (Chief Commercial Officer)
Employment Agreements
Adaptimmune Therapeutics PLC
Biotechnology
PA
2022
Rent Security Deposit Deed between MEPC Milton Park No. 1 Limited, MEPC Milton Park No. 2 Limited, Adaptimmune Limited, and Adaptimmune Therapeutics plc dated August 20, 2021
Escrow Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2021
Deed of Variation to Lease Agreement for 60 Jubilee Avenue, Milton Park between MEPC Milton Park No.1 & No.2 Limited, Adaptimmune Limited, and Adaptimmune Therapeutics PLC
Lease Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2021
Description of Ordinary Shares and American Depositary Shares of Adaptimmune Therapeutics plc Registered Under Section 12 of the Exchange Act
Stock Agreements
Adaptimmune Therapeutics PLC
Biotechnology
NY
2021
Employment Agreement between Adaptimmune, LLC and Elliot Norry dated December 16, 2020
Employment Agreements
Adaptimmune Therapeutics PLC
Biotechnology
PA
2020
Underwriting Agreement between Adaptimmune Therapeutics plc and Underwriters for Sale of American Depositary Shares (June 1, 2020)
Underwriting Agreements
Adaptimmune Therapeutics PLC
Biotechnology
NY
2020
Description of Ordinary Shares and American Depositary Shares of Adaptimmune Therapeutics plc Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
Adaptimmune Therapeutics PLC
Biotechnology
NY
2020
Collaboration and License Agreement between Universal Cells, Inc. and Adaptimmune Limited (January 13, 2020)
License Agreements
Adaptimmune Therapeutics PLC
Biotechnology
NY
2020
Service Agreement between Adaptimmune Limited and Gavin Wood (Chief Financial Officer) dated February 17, 2020
Employment Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2020
Variation Agreement to Client Agreement between La Fosse Associates Limited and Adaptimmune LLC (February 17, 2020)
Modification Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2020
Variation Agreement Amending Supplier Services Agreement Among La Fosse Associates Limited, GAR-1 Business Advisory Services, and Adaptimmune LLC
Modification Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2020
Underwriting Agreement between Adaptimmune Therapeutics plc and Cowen and Company, LLC for 21,000,000 American Depositary Shares
Underwriting Agreements
Adaptimmune Therapeutics PLC
Biotechnology
NY
2020
Employment Agreement between Adaptimmune, LLC and Elliot Norry dated January 13, 2020
Employment Agreements
Adaptimmune Therapeutics PLC
Biotechnology
PA
2020
Adaptimmune Therapeutics plc Senior Vice President Severance Policy (2019)
Severance Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2020
Framework Recruitment Services Agreement between La Fosse Associates Limited and Adaptimmune LLC
Services Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2019
Services Agreement between La Fosse Associates Limited, GAR-1 Business Advisory Services, and Adaptimmune LLC
Services Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2019
Collaboration Agreement between Adaptimmune Limited and Noile-Immune Biotech Inc.
Collaboration Agreements
Adaptimmune Therapeutics PLC
Biotechnology
NY
2019
Employment Agreement between Adaptimmune, LLC and John Lunger (August 1, 2019)
Employment Agreements
Adaptimmune Therapeutics PLC
Biotechnology
PA
2019
Collaboration Agreement between Adaptimmune Limited and AIS Operating Co., Inc. (Alpine Immune Sciences, Inc.)
Collaboration Agreements
Adaptimmune Therapeutics PLC
Biotechnology
NY
2019
Employment Agreement between Adaptimmune, LLC and Adrian Rawcliffe (CEO) dated June 26, 2019
Employment Agreements
Adaptimmune Therapeutics PLC
Biotechnology
PA
2019
Adaptimmune Therapeutics plc Non-Executive Director Appointment Letter with James Noble (June 2019)
Employment Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2019
Purchase Agreement for 10,000,000 American Depositary Shares between Adaptimmune Therapeutics plc and Purchasers
Purchase Agreements
Adaptimmune Therapeutics PLC
Biotechnology
NY
2018
Amendment Agreement No. 6 to Collaboration and Licence Agreement between Adaptimmune Limited and GlaxoSmithKline Intellectual Property Development Ltd.
Modification Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2018
Collaboration Agreement between Adaptimmune Limited and Cell Therapy Catapult Limited dated January 5, 2018
Collaboration Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2018
First Amendment to Employment Agreement between Adaptimmune, LLC and Gwendolyn Binder-Scholl
Employment Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2018
Rent Security Deposit Deed between MEPC Milton Park No. 1 & 2 Limited and Adaptimmune Limited (39 Innovation Drive)
Escrow Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2018
Adaptimmune Therapeutics plc 2015 Share Option Scheme Rules (as Amended)
Stock Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2018
Adaptimmune Therapeutics plc 2016 Employee Share Option Scheme Rules (as amended December 18, 2017)
Bonus & Incentive Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2018
Amendment Agreement No. 5 to Collaboration and Licence Agreement between Adaptimmune Limited and GlaxoSmithKline Intellectual Property Development Ltd.
Modification Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2017
Purchase Agreement for 7,000,000 American Depositary Shares between Adaptimmune Therapeutics plc and Matrix Capital Management Master Fund, LP (April 5, 2017)
Purchase Agreements
Adaptimmune Therapeutics PLC
Biotechnology
NY
2017
Adaptimmune Therapeutics plc Underwriting Agreement for 14,300,000 American Depositary Shares with Citigroup, Cowen, and Leerink
Underwriting Agreements
Adaptimmune Therapeutics PLC
Biotechnology
NY
2017
Co-Development and Co-Commercialisation Agreement between Adaptimmune Limited and Bellicum Pharmaceuticals, Inc.
Collaboration Agreements
Adaptimmune Therapeutics PLC
Biotechnology
TX
2017
Service Agreement between Adaptimmune Therapeutics PLC and J.J. Noble dated March 10, 2017
Employment Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2017
Employment Agreement between Adaptimmune, LLC and Rafael Amado
Employment Agreements
Adaptimmune Therapeutics PLC
Biotechnology
PA
2017
Employment Agreement between Adaptimmune, LLC and Gwendolyn Binder-Scholl (Chief Technology Officer)
Employment Agreements
Adaptimmune Therapeutics PLC
Biotechnology
PA
2017
Employment Agreement between Adaptimmune, LLC and Adrian Rawcliffe
Employment Agreements
Adaptimmune Therapeutics PLC
Biotechnology
PA
2017
Adaptimmune Therapeutics plc Executive Severance Policy (March 10, 2017)
Severance Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2017
Adaptimmune Therapeutics plc Non-Executive Director Appointment Letter with Giles Kerr (2016)
Employment Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2016
First Amendment to Employment Agreement between Adaptimmune, LLC and Adrian Rawcliffe
Employment Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2016
Services Agreement among Adaptimmune Limited, Adaptimmune LLC, and PCT, LLC (A Caladrius Company) dated September 13, 2016
Services Agreements
Adaptimmune Therapeutics PLC
Biotechnology
NY
2016
Strategic Collaboration Agreement between The University of Texas M. D. Anderson Cancer Center and Adaptimmune LLC/Adaptimmune Limited
Collaboration Agreements
Adaptimmune Therapeutics PLC
Biotechnology
TX
2016
Clinical Trial Collaboration and Supply Agreement between Merck Sharp & Dohme B.V. and Adaptimmune Limited (October 27, 2016)
Collaboration Agreements
Adaptimmune Therapeutics PLC
Biotechnology
NY
2016
Termination Agreement for Target Collaboration Deed between Immunocore Limited and Adaptimmune Limited
Termination Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2016
Adaptimmune Therapeutics plc Non-Executive Director Appointment Letter – David M. Mott
Employment Agreements
Adaptimmune Therapeutics PLC
Biotechnology
WI
2016
Adaptimmune Therapeutics plc Non-Executive Director Appointment Letter with Lawrence M. Alleva
Employment Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2016
Adaptimmune Therapeutics plc Non-Executive Director Appointment Letter – Ian Laing
Employment Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2016
Non-Executive Director Appointment Letter between Adaptimmune Therapeutics plc and Elliott Sigal, M.D., Ph.D.
Consulting Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2016
Adaptimmune Therapeutics plc Non-Executive Director Appointment Letter with Peter Thompson, M.D.
Consulting Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2016
Adaptimmune Therapeutics plc Non-Executive Director Appointment Letter – Kristen M. Hege, MD
Adaptimmune Therapeutics PLC
Biotechnology
2023
Deed of Surrender of Part of Lease – MEPC Milton Park No.1 & No.2 Limited and Adaptimmune Limited (39 Innovation Drive)
Lease Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2022
Deed of Variation to Lease Agreement for 39 Innovation Drive, Milton Park between MEPC Milton Park No.1 & No.2 Limited and Adaptimmune Limited
Lease Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2022
Deed of Variation to Lease Agreement for 39 Innovation Drive, Milton Park between MEPC Milton Park No. 1 & 2 Limited and Adaptimmune Limited
Lease Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2021
Agreement Regarding Lease Variations and Rent Security Deposit for 39 Innovation Drive and 60 Jubilee Avenue, Milton Park (MEPC Milton Park No. 1 Limited, MEPC Milton Park No. 2...
Lease Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2021
Adaptimmune Therapeutics PLC CEO Transition and Variation Agreement with James Julian Noble (June 2019)
Transition Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2019
Variation Agreement to Service Agreement between Adaptimmune Therapeutics PLC and James Julian Noble (June 26, 2019)
Modification Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2019
Lease Agreement for 39 Innovation Drive, Milton Park between MEPC Milton Park No. 1 & No. 2 Limited and Adaptimmune Limited
Lease Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2018
Non-Executive Director Appointment Letter between Adaptimmune Therapeutics plc and Dr. Tal Zaks
Adaptimmune Therapeutics PLC
Biotechnology
2016
Lease Agreement for 60 Jubilee Avenue, Milton Park between MEPC Milton Park No. 1 & 2 Limited and Adaptimmune Limited
Lease Agreements
Adaptimmune Therapeutics PLC
Biotechnology
2016
Adaptimmune Therapeutics plc Non-Executive Director Appointment Letter with Ali Behbahani, M.D.
Adaptimmune Therapeutics PLC
Biotechnology
WI
2016